Session

IBD (Posters)

RISK OF AND RISK FACTORS FOR COLORECTAL CANCER IN ULCERATIVE COLITIS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT
RISK OF AND RISK FACTORS FOR COLORECTAL CANCER IN ULCERATIVE COLITIS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2018, DATA FROM THE VESZPREM COUNTY COHORT

LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS OVER DIFFERENT ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT
LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS OVER DIFFERENT ERAS – A POPULATION-BASED STUDY FROM WESTERN HUNGARY BETWEEN 1977–2020, DATA FROM THE VESZPREM COUNTY COHORT

EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT
EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM COLECTOMY RATES IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT

INCIDENCE, PREVALENCE, DISEASE PHENOTYPE AND MAXIMAL THERAPEUTIC STEP IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT
INCIDENCE, PREVALENCE, DISEASE PHENOTYPE AND MAXIMAL THERAPEUTIC STEP IN ULCERATIVE COLITIS PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT

EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN CROHN’S DISEASE PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT
EVOLUTION OF DISEASE PHENOTYPE, TIME TO BIOLOGICAL THERAPY AND MEDIUM-, LONG-TERM SURGERY RATES IN CROHN’S DISEASE PATIENTS IN WESTERN HUNGARY – A POPULATION-BASED STUDY BETWEEN 2007–2018, DATA FROM THE VESZPREM COUNTY COHORT

EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?
EARLY INTERVENTION WITH BIOLOGICS IN CROHN'S DISEASE - HOW EARLY IS EARLY?

NEUTROPHIL-LYMPHOCYTE RATIO ROLE TO PREDICT DISEASE ACTIVITY AND SEVERITY IN ULCERATIVE COLITIS
NEUTROPHIL-LYMPHOCYTE RATIO ROLE TO PREDICT DISEASE ACTIVITY AND SEVERITY IN ULCERATIVE COLITIS

IMPACT OF BIOLOGIC THERAPIES AND SMALL MOLECULES ON THE RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
IMPACT OF BIOLOGIC THERAPIES AND SMALL MOLECULES ON THE RISK OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN ULCERATIVE COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

EFFECTS OF ANTI-TNF-ALPHA AND ANTI-ALPHA4BETA7 DRUGS ON CIRCULATING DENDRITIC CELLS MIGRATORY CAPACITY IN INFLAMMATORY BOWEL DISEASE
EFFECTS OF ANTI-TNF-ALPHA AND ANTI-ALPHA4BETA7 DRUGS ON CIRCULATING DENDRITIC CELLS MIGRATORY CAPACITY IN INFLAMMATORY BOWEL DISEASE

EVALUATION OF STRESS, ANXIETY, DEPRESSION LEVELS AND INTESTINAL GENE EXPRESSION IN NEWLY DIAGNOSED IBD PATIENTS
EVALUATION OF STRESS, ANXIETY, DEPRESSION LEVELS AND INTESTINAL GENE EXPRESSION IN NEWLY DIAGNOSED IBD PATIENTS

CYTOMEGALOVIRUS IN INFLAMMATORY BOWEL DISEASE: USEFULNESS OF A POSITIVE RESULT WITH DIFFERENT DIAGNOSTIC TECHNIQUES IN TREATMENT CHOICE
CYTOMEGALOVIRUS IN INFLAMMATORY BOWEL DISEASE: USEFULNESS OF A POSITIVE RESULT WITH DIFFERENT DIAGNOSTIC TECHNIQUES IN TREATMENT CHOICE

VIRTUAL BIOLOGICS CLINIC: A STREAMLINED MULTI-DISCIPLINARY TEAM (MDT) APPROACH TO IMPROVE INFLAMMATORY BOWEL DISEASE (IBD) CARE
VIRTUAL BIOLOGICS CLINIC: A STREAMLINED MULTI-DISCIPLINARY TEAM (MDT) APPROACH TO IMPROVE INFLAMMATORY BOWEL DISEASE (IBD) CARE

EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION
EFFICACY AND SAFETY OF USTEKINUMAB FOR ULCERATIVE COLITIS THROUGH 4 YEARS: FINAL RESULTS FROM THE UNIFI LONG-TERM EXTENSION

CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION
CORTICOSTEROID-SPARING EFFECTS OF USTEKINUMAB THERAPY FOR ULCERATIVE COLITIS THROUGH 4 YEARS: UNIFI LONG-TERM EXTENSION

AN INSIDE OUT APPROACH TO IDENTIFY PERIPHERAL PATIENT PATHOTYPE-SPECIFIC BIOMARKERS FROM A HIGH-CONTENT, MULTI-DIMENSIONAL DATASET OF HETEROGENOUS IBD POPULATIONS
AN INSIDE OUT APPROACH TO IDENTIFY PERIPHERAL PATIENT PATHOTYPE-SPECIFIC BIOMARKERS FROM A HIGH-CONTENT, MULTI-DIMENSIONAL DATASET OF HETEROGENOUS IBD POPULATIONS

REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
REAL-WORLD EVIDENCE OF THE EFFECTIVENESS AND SAFETY OF USTEKINUMAB FOR THE TREATMENT OF CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES

RISK OF POLYPS AND COLORECTAL CANCER IN PATIENTS WITH MICROSCOPIC COLITIS: CASE-CONTROL STUDY WITH LONG-TERM FOLLOW-UP
RISK OF POLYPS AND COLORECTAL CANCER IN PATIENTS WITH MICROSCOPIC COLITIS: CASE-CONTROL STUDY WITH LONG-TERM FOLLOW-UP

IMPACT OF THE HLA-DQA1*05 ALLELE ON LOSS OF RESPONSE AND PRESENCE OF ANTI-DRUG ANTIBODIES TO USTEKINUMAB IN CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS
IMPACT OF THE HLA-DQA1*05 ALLELE ON LOSS OF RESPONSE AND PRESENCE OF ANTI-DRUG ANTIBODIES TO USTEKINUMAB IN CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS

IBD (Posters)

HEALTHCARE UTILISATION WITH USTEKINUMAB TREATMENT IN A REAL-WORLD COHORT IN NORTH WEST LONDON: AN ANALYSIS BY AGE AND LINE OF THERAPY
HEALTHCARE UTILISATION WITH USTEKINUMAB TREATMENT IN A REAL-WORLD COHORT IN NORTH WEST LONDON: AN ANALYSIS BY AGE AND LINE OF THERAPY

THE DISEASE SEVERITY INDEX FOR INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH PSYCHOLOGICAL SYMPTOMS, QUALITY OF LIFE, AND PREDICTS A MORE COMPLICATED DISEASE COURSE
THE DISEASE SEVERITY INDEX FOR INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH PSYCHOLOGICAL SYMPTOMS, QUALITY OF LIFE, AND PREDICTS A MORE COMPLICATED DISEASE COURSE

Item 261 - 280 / 612
1 2 3 4 5 6 7 8 9 10 11 12 13
14
15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31